课题基金 / 基金详情

项目摘要

项目成果

RICHARD C MULLIGAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The ability to 'exogenously' control the expression of genes in mammalian cells has been a powerful tool of biomedical research. In particular, gene regulation technology has played a major role in efforts to understand the role of specific gene products in fundamental biological processes and in development and disease states. The technology also offers the opportunity to have a major impact in a number of other areas of research and could even form an important basis for new therapeutic paradigms. However, due to limitations of existing systems, there is a need for the development of new methods for achieving gene regulation in order to realize the full potential of the technology. The focus of this grant proposal is the development of a new technology platform for gene regulation which involves the modulation of RNA self-cleavage, rather than transcription, as a means of controlling gene expression. The basis for the proposed research program are recent studies in our laboratory which demonstrate that incorporation of sequences encoding self-cleaving RNA motifs, ribozymes (rz), into a mammalian transcription unit can lead to the elimination of gene expression from the resulting transcript, due to efficient self-cleavage of the mRNA. In turn, we have shown that gene expression from such a configuration can be effectively 'induced' via inhibition of RNA self-cleavage using small molecule inhibitors. We believe that such a system for gene regulation may offer distinct advantages over existing systems for controlling gene expression and could have broad experimental and therapeutic application. The overall objective of the research program described here is to further understand the experimental parameters which govern efficient RNA self-cleavage in mammalian cells, and to apply that knowledge, in conjunction with development of new methodologies for the manipulation of rz self-cleavage and standard gene transfer technology, to the development of a widely applicable and 'user-friendly' technology platform for gene regulation. An important goal of the research program will be to establish a general methodology for the development of 'custom-designed' rz-based gene regulation systems tailored to respond to any specific small molecule or other molecular entity.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
A mammalian cell-based assay for screening inhibitors of RNA cleavage.
一种基于哺乳动物细胞的检测方法,用于筛选 RNA 切割抑制剂。
DOI: 10.1007/978-1-59745-558-9_24
发表时间: 2009
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Yen,Laising, Stockwell,BrentR, Mulligan,RichardC]
通讯作者: Mulligan,RichardC
Engineered in vivo nuclear fusion: application to regenerative medicine
  • 批准号:
    7833374
  • 项目类别:
  • 资助金额:
    $47.62万
  • 财政年份:
    2009
  • 负责人:
    RICHARD C MULLIGAN
  • 依托单位:
Engineered in vivo nuclear fusion: application to regenerative medicine
  • 批准号:
    7936800
  • 项目类别:
  • 资助金额:
    $48.96万
  • 财政年份:
    2009
  • 负责人:
    RICHARD C MULLIGAN
  • 依托单位:
Improving the Safety Profile of Lentiviral Vectors
  • 批准号:
    7837755
  • 项目类别:
  • 资助金额:
    $31.88万
  • 财政年份:
    2007
  • 负责人:
    RICHARD C MULLIGAN
  • 依托单位:
Improving the Safety Profile of Lentiviral Vectors
  • 批准号:
    7634476
  • 项目类别:
  • 资助金额:
    $32.2万
  • 财政年份:
    2007
  • 负责人:
    RICHARD C MULLIGAN
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: